Opiant Pharmaceuticals Statistics Share Statistics Opiant Pharmaceuticals has 5.27M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 5.27M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 41.5% Shares Floating 4.38M Failed to Deliver (FTD) Shares 33 FTD / Avg. Volume 0.05%
Short Selling Information The latest short interest is 33.86K, so 0% of the outstanding
shares have been sold short.
Short Interest 33.86K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is 49.8 and the forward
PE ratio is null.
Opiant Pharmaceuticals's PEG ratio is
-0.2.
PE Ratio 49.8 Forward PE n/a PS Ratio 3.68 Forward PS n/a PB Ratio 3.2 P/FCF Ratio 77.79 PEG Ratio -0.2
Financial Ratio History Enterprise Valuation Opiant Pharmaceuticals has an Enterprise Value (EV) of 129.08M.
EV / Sales 3.17 EV / EBITDA 22.14 EV / EBIT 67 EV / FCF 67
Financial Position The company has a current ratio of 10.1,
with a Debt / Equity ratio of 0.36.
Current Ratio 10.1 Quick Ratio 442.49 Debt / Equity 0.36 Debt / EBITDA 2.93 Debt / FCF 8.87 Interest Coverage 2.42
Financial Efficiency Return on Equity is 6.42% and Return on Invested Capital is 8%.
Return on Equity 6.42% Return on Assets 4.27% Return on Invested Capital 8% Revenue Per Employee $1.1M Profits Per Employee $81.32K Employee Count 37 Asset Turnover 0.58 Inventory Turnover n/a
Taxes Income Tax 24.27K Effective Tax Rate 0.8%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0.83, so Opiant Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.83 52-Week Price Change n/a 50-Day Moving Average 20.48 200-Day Moving Average 14.66 Relative Strength Index (RSI) 50.13 Average Volume (20 Days) 72,355
Income Statement In the last 12 months, Opiant Pharmaceuticals had revenue of 40.73M
and earned 3.01M
in profits. Earnings per share was 0.68.
Revenue 40.73M Gross Profit 31.66M Operating Income 5.16M Net Income 3.01M EBITDA 5.83M EBIT 5.16M Earnings Per Share (EPS) 0.68
Full Income Statement Balance Sheet The company has 37.85M in cash and 17.08M in
debt, giving a net cash position of 20.77M.
Cash & Cash Equivalents 37.85M Total Debt 17.08M Net Cash 20.77M Retained Earnings -61.68M Total Assets 41.95M Working Capital 31.51M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 1.93M
and capital expenditures 0, giving a free cash flow of 1.93M.
Operating Cash Flow 1.93M Capital Expenditures n/a Free Cash Flow 1.93M FCF Per Share 0.43
Full Cash Flow Statement Margins Gross margin is 77.74%, with operating and profit margins of 12.66% and 7.39%.
Gross Margin 77.74% Operating Margin 12.66% Pretax Margin 7.45% Profit Margin 7.39% EBITDA Margin 14.31% EBIT Margin 12.66% FCF Margin 4.73%
Dividends & Yields OPNT does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 2.01% FCF Yield 1.29%
Dividend Details Analyst Forecast Currently there are no analyst rating for OPNT.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $3.4 Lynch Upside -83.54% Graham Number 12.64 Graham Upside -38.79%
Stock Splits The last stock split was on Dec 31, 2014. It was a
backward
split with a ratio of 1:100.
Last Split Date Dec 31, 2014 Split Type backward Split Ratio 1:100
Scores Altman Z-Score 2.86 Piotroski F-Score 4
